KEY FEATURES
Full Name | Apoptotic Peptidase Activating Factor 1 |
---|---|
Synonym | CED4; Apoptotic Protease Activating Factor |
Assay Type | Sandwich |
Reactivity | Human |
Range | 0.15-10ng/mL |
Sensitivity | 0.06ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human APAF1 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human APAF1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human APAF1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human APAF1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human APAF1. You can calculate the concentration of Human APAF1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human APAF1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 0.55 | 1.45 | 4.56 | 0.54 | 1.31 | 4.22 |
Standard deviation | 0.03 | 0.08 | 0.23 | 0.03 | 0.06 | 0.16 |
CV(%) | 5.33 | 5.68 | 5.11 | 5.04 | 4.84 | 3.71 |
RECOVERY
The recovery of Human APAF1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 85-100 | 92 |
EDTA plasma (n=8) | 87-99 | 93 |
Cell culture media (n=8) | 88-101 | 95 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human APAF1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Pathways associated with ELISA Kit
Activation Of Caspases Through Apoptosome-mediated Cleavage Pathway | Activation Of Caspases Through Apoptosome-mediated Cleavage Pathway |
Alzheimer's Disease Pathway | Alzheimer's Disease Pathway |
Alzheimers Disease Pathway | Alzheimers Disease Pathway |
Amyotrophic Lateral Sclerosis (ALS) Pathway | Amyotrophic Lateral Sclerosis (ALS) Pathway |
Apoptosis Pathway | Apoptosis Pathway |
Diseases associated with APAF1 ELISA Kit
Neoplasms | publications with APAF1 and Neoplasms |
Necrosis | publications with APAF1 and Necrosis |
Carcinoma | publications with APAF1 and Carcinoma |
Nervous System Diseases | publications with APAF1 and Nervous System Diseases |
Breast Neoplasms | publications with APAF1 and Breast Neoplasms |
Inflammation | publications with APAF1 and Inflammation |
Liver Diseases | publications with APAF1 and Liver Diseases |
Neoplasms, Experimental | publications with APAF1 and Neoplasms, Experimental |
Colonic Neoplasms | publications with APAF1 and Colonic Neoplasms |
Nerve Degeneration | publications with APAF1 and Nerve Degeneration |
Organs/Tissues associated with APAF1 ELISA Kit
Brain | publications with APAF1 and Brain |
Blood | publications with APAF1 and Blood |
Muscle | publications with APAF1 and Muscle |
Liver | publications with APAF1 and Liver |
Heart | publications with APAF1 and Heart |
Embryonic Tissue | publications with APAF1 and Embryonic Tissue |
Eye | publications with APAF1 and Eye |
Skin | publications with APAF1 and Skin |
Kidney | publications with APAF1 and Kidney |
Thymus | publications with APAF1 and Thymus |